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ABSTRACT 
Objective: Polyherbal formulation (PHF) is prepared from five herbs; these herbs are well-known and widely used in the traditional system of 
medicine for the treatment of diabetes and various diseases. Individually, each herb is completely safe, but the combined effects of these herbs are 
not known. Thus, the main objective of the present study was to assess the toxicological profile of PHF by acute and sub-acute oral toxicity in rats.  
Methods: The acute and sub-acute oral toxicity study was carried out as per OECD guidelines 423 and 407 respectively. In the acute toxicity study 
female albino Wistar rats administered single oral dose (2000 mg/kg) of PHF, while in sub-acute toxicity study male and female albino Wistar rats 
administered daily oral doses (100, 200 and 400 mg/kg) of PHF for 28 d. At the end of the study, the animals were humanely sacrificed and assessed 
for the effect of PHF on body weight and relative organ weights and hematological, biochemical and histopathological parameters.  
Results: In the acute toxicity study no mortality or behavioral changes were observed in rats treated with a single dose of PHF (2000 mg/kg) 
indicating that the LD50
Conclusion: These results exhibit the absence of acute and sub-acute oral toxicity after treatment of PHF in rats. However, further studies in 
animals and in humans are needed in order to have sufficient safety evidence for its use in humans. 
 is higher than 2000 mg/kg. In the sub-acute toxicity study, PHF was administered at three dose levels (100, 200 and 400 
mg/kg), showed no significant changes in body weight and relative organ weights and hematological, biochemical and histopathological parameters.  
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INTRODUCTION 
In the modern era, herbal formulations have gained greater 
importance than ever before, mainly due to their efficacy and easy 
availability as well as less side effects as compared to the synthetic 
drugs [1]. A World Health Organization survey indicated that 70 to 
80% of the global population depends on alternative medicine, 
predominantly herbal in nature, in their primary health care [2]. The 
uses of medicinal plants as a source of drugs in primary health care 
have become popular universally, particularly in developing 
countries as a safe because of natural source [3].  
All the extracts of herbs used for the study were obtained by 
supercritical fluid extraction (SFE) method, and they are called 
holistic extract. They are pure, highly powerful and extremely 
concentrated and free from any residues of chemical insecticides, 
pesticides & herbicides. SFE is used on a large scale for the 
extraction of some food grade and essential oils and pharmaceutical 
products from plants [4]. SFE allows the processing of plant material 
at low temperatures, hence limiting, thermal degradation, and 
avoids the use of toxic solvents [5]. 
Emblica officinalis, Gymnema sylvestre, Terminalia arjuna, Tinospora 
cordifolia and Zingiber officinale are well-known herbs available 
throughout India and widely used in the traditional system of 
medicine for the treatment of diabetes and various ailments.  
The polyherbal formulation contained proven antidiabetic, anti-
oxidant, antihyperlipidemic and cardiotonic herbs that alone or in 
combination control diabetes and diabetic complications. Emblica 
officinalis [6] have hypoglycemic and hypolipidemic activities, 
Gymnema sylvestre [7] have strong anti-hyperglycemic activity, 
Terminalia arjuna [8] is a vital cardiotonic herb, Tinospora cordifolia 
[9-10] possesses hypoglycemic and antioxidant activities 
and Zingiber officinale
The safeties of these individual herbs are well known, but the 
combined effects of these herbs are unclear. Thus, it becomes 
essential to evaluate the safety and toxicity of the combination of 
herbs (PHF), before their use in human. Preclinical toxicity studies 
are necessary for determining a safe dose for human trials. 
Therefore the objective of the present study, to assess the safety of 
PHF by acute oral toxicity (single dose, 14 d) and sub-acute oral 
toxicity (repeated doses for 28
 [11] powerful antioxidant, antidiabetic and 
hypolipidemic activities.  
th
MATERIALS AND METHODS 
 days) of PHF in albino Wister rats, 
the study was done according to the Organization for Economic Co-
operation and Development (OECD) guidelines 423 and 407 
respectively. 
Materials 
Drugs and chemicals  
Carboxymethyl cellulose-High Viscosity (Loba Chemie Pvt. Ltd., 
Mumbai), anesthetic ether (Narsons Pharma, Andhra Pradesh), single 
pan electronic balance (Ohaus Corp., USA), weighing balance (Sansui 
Electronics Pvt. Ltd., Pune), metabolic cages (Orchid, Nashik). All other 
chemicals used in this study were of analytical grade. 
Holistic extracts 
All the extracts were obtained by supercritical fluid extraction 
method, and they were procured from Nisarga Biotech Pvt. Ltd, 
Satara as a gift sample. 
Experimental animals 
Albino Wistar rats of either sex weighing 180-200g±20 were 
procured from Shri Venkateshwara Enterprises, Banglore. All 
animals were maintained under standard laboratory conditions of 
temperature (22±2 °C) and humidity 50±15% with 12 h day: 12 h 
night cycle. Rats had free access to water and rodent pellet diet 
(Hindustan Lever Ltd, Bangalore, India). Animals were acclimatized 
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to laboratory conditions one week prior to initiation of experiments. 
The experimental protocol has been approved by the institutional 
animal ethics committee of the Satara College of Pharmacy, Satara 
(protocol approval no. is SCOP/IAEC/38) and all the animal 
experiments were carried out according to CPCSEA guidelines. 
Methods 
Preparation of polyherbal formulation 
The polyherbal formulation was prepared by mixing all the five 
holistic extracts by taking equal quantity and adding 1% CMC 
solution as a surfactant, continuously triturating till uniform 
suspension are formed.  
Toxicity studies 
An acute and sub-acute oral toxicity studies were conducted in 
accordance with the Organization for Economic Co-operation and 
Development (OECD) Guideline 423 and 407 respectively [12-13].  
Acute oral toxicity 
Determination of LD50
The PHF was administered in a single dose by gavage using a 
stomach tube. Rats overnight fasted prior to dosing. The starting 
dose level was 300 mg/kg. Before dose administration, the body 
weight of each animal was determined, and the dose was calculated 
according to the body weight. Three female rats were used for each 
step, sequentially dosed at intervals of 48 h. Animals were observed 
individually after dosing during first 30 min and periodically during 
the first 24 h, with special attention given during the first 4 h and 
daily thereafter, for a total of 14 d. An acute oral toxicity study was 
conducted in accordance with OECD Guideline 423 [14]. 
 of PHF 
Effect of PHF on gross symptoms of toxicity 
The five parameters of the Hippocratic screening were analyzed: 
conscious state (general activity); activity and coordination of motor 
system and muscle toning (response to tail touch and grip, 
straightening, strength to grab); reflexes (corneal and headset); 
activities on the central nervous system (tremors, convulsions, 
straub, sedation, anesthesia and ataxia) and activities on the 
autonomic nervous system (lacrimation, cyanosis, ptosis, salivation 
and piloerection) [15-16]. The water and feed intake were recorded 
daily, and body weight recorded weekly. 
Subacute oral toxicity 
The repeated doses for oral toxicity studies were carried out in rats, 
according to the OECD test guideline 407. The rats were divided 
randomly into 4 groups of 10 animals each (5 males and 5 females). 
Group I served as a vehicle control and received only 1% CMC 
solution. Groups II, III and IV received PHF orally at the doses of 100, 
200, 400 mg/kg, respectively, every day for 28 d.  
The PHF was administered orally by gavage, as a single dose at 
similar times each day. For all the dose groups, volume (10 
ml/kg) was adjusted and rounded up to single decimal point as 
per the body weight for an individual animal throughout the 
treatment period. During this period, all the animals were 
observed daily for signs of toxicity and mortality. The changes in 
body weight, food and water intake and clinical signs were also 
observed and recorded [17]. 
Hematological and biochemical examination 
All experimental animals were humanely sacrificed at the end of the 
experiment by anesthetic ether in desiccators. Blood samples were 
collected by cardiac puncture for subsequent hematological and 
biochemical analysis. The hematological parameters were analyzed 
such as hemoglobin, Hematocrit, platelet count, RBC, WBC, 
neutrophil, eosinophils, basophils, lymphocyte and monocyte [17].  
The biochemical parameters were also analyzed such as glucose, 
total bilirubin, cholesterol and triglyceride, markers of renal 
function (urea and creatinine) and liver (ALT, AST and ALP) and 
protein profile (total protein, albumin and globulin) [18]. 
Histopathological examination 
All experimental animals were humanely sacrificed at the end of the 
experiment by anesthetic ether in a desiccator. After collecting a 
blood sample, the vital organs (heart, lung, kidney, liver, and spleen) 
and reproductive organs (testis, ovary) were trimmed of any 
adherent tissue, and their wet weight was taken as soon as possible 
after dissection to avoid drying. Organ/body weight ratios were 
calculated based on the fasted animal's body weight. Then samples 
of kidney and liver were fixed in 10% neutral buffered formalin, 
embedded in paraffin, sectioned at 5 μm, and stained with 
hematoxylin and eosin, following the standard laboratory 
procedures. The stained sections were examined under a 
microscope for any cellular damage or change in morphology [17]. 
Statistical analysis 
Results were expressed as mean±standard error of the mean (SEM). 
Student’s t-test was used for comparison between the two 
experimental groups (acute toxicity). The differences between 
groups of sub-acute toxicity were determined by analysis of variance 
(one-way ANOVA) followed by Dunnett’s multiple comparison tests 
(Graph pad Instant-version 3.00). Probability values of 0.05 (p<0.05) 
or less were considered statistically significant. 
RESULTS 
Acute oral toxicity 
Determination of LD50
The acute toxicity of PHF was determined as per the OECD guideline 
423, where the limit test dose was 2000 mg/kg, at this dose PHF did 
not cause the death of any animal. Therefore, the PHF seems to be 
safe at a dose level of 2000 mg/kg, and the LD
 of PHF 
50
There were no noticeable changes in the general behavior as well as 
no changes in water and food intake in treated groups. However, 
some of the rats showed signs of sedation, lethargy, and drowsiness 
after the administration of PHF at a dose of 2000/kg, when 
compared to control group. The absence of any sign of toxicity and 
mortality in the treated group rates at the end of the 14 d 
observation period indicated that the PHF showed no toxic effects in 
the test animals.  
 was considered to 
be>2000 mg/kg. The control group rats and the PHF treated rats 
were observed for first 30 min, then for a short period (4 h) followed 
by long periods (24 h) and then daily thereafter, for a 14 d.  
Subacute oral toxicity 
Daily oral administration of PHF at doses of 100, 200 and 400 mg/kg 
for 28 consecutive days did not produce any abnormality and sign of 
toxicity in rats of either sex. The doses were selected based on the 
results of acute toxicity study wherein; the PHF was found to be safe 
up to a dose of 5000 mg/kg body weight. 
Effects of PHF on clinical signs of toxicity and mortality 
The sub-acute toxicity study of the PHF was determined as per OECD 
guideline 407. In the present study, after 28 d treatment of PHF, the 
animals were active and responsive to stimuli; there were no clinical 
signs of toxicity and mortality. Three groups of animals daily treated 
with PHF at the dose of 100, 200 and 400 mg/kg were survived 
throughout the study.  
There was no noticeable change in the general behavior of male and 
female rats treated at 100, 200 and 400 mg/kg. However, sub-acute 
administration of the PHF at the highest dose (400 mg/kg) caused 
mild changes in the general behavior such as hypoactivity was 
observed in female rats, corroborating the hypothesis of the no 
toxicity of the PHF after sub-acute administration. 
Effect of PHF on body weight, water, and food intake 
After administration of a single dose of PHF (2000 mg/kg), no 
significant changes occurred in body weight, water, and food intake 
in female and male rats. Both the control and treated rats appeared 
healthy at the end and throughout the 14 d study (table 1). In sub-
acute toxicity study, there were insignificant decreases in body 
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weight gains of male and female rats treated with repeated oral doses 
of PHF (100, 200 and 400 mg/kg), when compared to the control 
group. No significant changes in water and food intake in treated 
groups when compared with a control group of rats (table 2). 
  
Table 1: Effect of single dose of PHF on body weights, food and water intake of female rats in acute toxicity 
Group  Sex  Body weight (g) Weight gain (%) Food intake (g/day) Water intake (ml/day) 
Day 0 Day 14 
Control  Female 186.5±2.55 244.33±3.63 23.97 141.5±2.71 199.83±5.85 
PHF-2000 mg/kg Female 191.16±4.62 236.83±3.29 19.28 132.16±2.99 186.83±4.02 
Values are expressed as mean±SEM, P>0.05 when compared to control group., PHF=Polyherbal formulation 
 
Table 2: Effect of PHF on body weights, food and water intake of female rats in sub-acute toxicity 
Group Sex Body weight (g) Weight gain (%) Food intake (g/day) Water intake (ml/day) 
Day 0 Day 28 
Control  Female 189.5±3.19 285.00±4.15 33.50 139.5±2.27 209.00±4.90 
Male 194.5±5.25 347.83±3.88 44.00 151.33±3.98 142.16±4.18 
PHF-100 mg/kg  Female 194.0±3.22 279.50±4.93 30.00 136.5±2.07 203.16±7.49 
Male 197.8±6.68 341.83±5.58 42.12 143.0±4.03 135.83±2.45 
PHF-200 mg/kg Female 190.5±2.39 270.00±3.92 28.30 134.00±2.36 201.33±6.50 
Male 204.0±5.60 336.66±3.85 39.40 139.66±3.57 132.5±2.39 
PHF-400 mg/kg Female 188.8±2.39 259.00±3.53 27.41 132.5±2.14 199.66±4.58 
Male 201.83±6.36 326.5±4.75 38.08 137.33±4.07 131.33±2.89 
Values are expressed as mean±SEM, P>0.05 when compared to control group. PHF=Polyherbal formulation 
 
Effect PHF on hematological parameters 
Oral administration of the PHF for 28 d at a dose of 100, 200 and 
400 mg/kg did not cause significant changes in hematological 
parameters when compared with control group rats.  
The hemoglobin, hematocrit, platelet count, RBC, WBC, neutrophil, 
eosinophil, basophil, lymphocyte and monocyte in the treated rats 
were compared with control rats (table 3).  
Effect of PHF on biochemical parameters 
Oral administration of the PHF for 28 d at a dose of 100, 200 and 400 
mg/kg did not cause significant changes in serum biochemical 
parameters such as glucose, AST, ALT, ALP, total bilirubin, total 
protein, albumin, urea, creatinine, cholesterol and triglyceride levels, 
when compared to control group. However, treatment of PHF was 
shown in significantly decreased blood glucose level in female and 
male rats, when compared with the respective control group (table 4). 
Effect of PHF on relative organ weight  
There were no significant differences in relative organ weight between 
control rats and PHF treated rats at a dose of 100, 200 and 400 mg/kg. 
The relative organ weight of control rats and PHF treated rats 
statistically insignificant. The results revealed that the vital organs 
such as liver, kidney, spleen, heart, lung, ovary and testis were not 
adversely affected throughout the treatment by PHF (table 5). 
 
Table 3: Effect of PHF on hematological parameters of male and female rats in sub-acute toxicity 
Parameters Sex Group 
Control  PHF-100 mg/kg  PHF-200 mg/kg  PHF-400 mg/kg  
Hemoglobin (g/dl)  Female 14.21±0.72 13.71±0.54 13.95±0.47 13.45±0.67 
Male 16.35±0.39 15.56±0.44 15.33±0.57 15.43±0.49 
Hematocrit (%) Female 43.5±1.97 40.33±2.06 44.66±1.74 43.00±2.08 
Male 45.5±2.07 47.83±1.53 48.66±2.17 44.33±1.82 
Platelet count (103 Female /µl)  579.83±31.53 560.33±21.78 594.0±33.61 610.50±31.02 
Male 481.66±43.57 475.50±23.07 491.50±33.21 517.33±29.62 
RBC (106 Female /µl) 7.75±0.37 7.18±0.33 7.55±0.38 7.28±0.37 
Male 8.91±0.51 8.31±0.38 8.18±0.33 8.41±0.36 
WBC (103 Female /µl)  7.46±0.29 7.33±0.40 7.21±0.39 7.41±0.41 
Male 9.10±0.34 9.26±0.35 9.60±0.48 9.13±0.38 
Neutrophils (%)  Female 21.33±1.43 20.83±1.13 21.16±1.51 21.83±1.92 
Male 20.50±1.66 21.50±0.88 22.00±1.15 21.66±1.82 
Eosinophils (%) Female 1.53±0.12 1.30±0.15 1.46±0.16 1.41±0.13 
Male 1.53±0.15 1.38±0.16 1.45±0.19 1.51±0.17 
Basophils (%) Female 0.46±0.04 0.55±0.02 0.48±0.04 0.51±0.03 
Male 0.46±0.05 0.55±0.03 0.52±0.03 0.49±0.04 
Lymphocyte (%) Female 69.16±3.13 72.66±3.33 71.5±3.24 75.00±3.43 
Male 76.86±3.47 73.83±3.12 70.16±2.88 72.33±3.24 
Monocyte (%) Female 4.03±0.23 4.30±0.33 4.50±0.29 4.26±0.35 
Male 4.06±0.19 4.45±0.38 4.80±0.31 4.58±0.36 
Values are expressed as mean±SEM (n=10) in each group. P>0.05, when compared to control groups. (One-way ANOVA followed by Dunnett's 
multiple comparison test) PHF (Polyherbal formulation), WBC (white blood cell count), RBC (red blood cell count) 
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Table 4: Effect of PHF on Biochemical parameters of male and female rats in sub-acute toxicity 
Parameters Sex Group 
Control  100 mg/kg  200 mg/kg  400 mg/kg  
Glucose (mg/dl) Female 89.16±2.97 82.5±2.70 75.83±3.92 78.83±4.18 
Male 90.5±4.76 87.83±3.09 81.66±3.50 75.16±4.03 
AST (U/l) Female 71.16±4.96 75.83±4.65 67.0±2.76 74.16±2.49 
Male 69.5±2.77 72.83±3.70 74.00±4.21 77.16±4.09 
ALT (U/l) Female 32.66±1.90 33.66±2.30 35.0±2.01 38.16±2.90 
Male 29.33±2.26 31.83±2.52 34.50±2.43 32.83±2.04 
ALP (U/l) Female 1.06±0.28 1.11±0.28 1.18±0.30 1.21±0.28 
Male 1.05±0.12 1.08±0.10 1.11±0.13 1.13±0.15 
Total bilirubin (mg/dl)  Female 1.83±0.10 1.96±0.11 1.91±0.20 2.01±0.19 
Male 1.74±0.03 1.79±0.04 1.84±0.05 1.97±0.10 
Total protein (g/dl)  Female 7.2±0.27 6.98±0.25 6.56±0.25 6.66±0.29 
Male 7.51±0.57 7.30±0.42 7.20±0.28 6.98±0.37 
Albumin (g/dl)  Female 4.53±0.20 4.51±0.16 4.37±0.20 4.28±0.27 
Male 4.54±0.04 4.52±0.05 4.57±0.05 4.49±0.04 
Globulin (g/dl)  Female 2.95±0.22 3.13±0.24 3.08±0.16 3.18±0.25 
Male 3.01±0.08 2.78±0.07 2.86±0.06 2.89±0.05 
Urea (mg/dl)  Female 25.66±1.99 29.83±1.66 27.00±1.69 30.6±1.92 
Male 22.17±1.79 25.31±1.45 24.44±1.70 26.54±1.36 
Creatinine (mg/dl)  Female 0.50±0.02 0.53±0.03 0.54±0.03 0.57±0.02 
Male 0.52±0.03 0.54±0.02 0.57±0.03 0.55±0.02 
Cholesterol (mg/dl) Female 86.00±3.75 89.16±3.76 94.33±2.56 98.16±3.50 
Male 81.66±3.0 89.50±3.73 86.50±3.09 91.83±3.36 
Triglycerides (mg/dl) Female 60.33±3.25 63.33±3.0 64.66±2.51 61.86±2.48 
Male 58.33±3.20 55.5±3.40 65.33±3.21 58.66±2.91 
Values are expressed as mean±SEM (n=10) in each group. P>0.05, when compared to control groups. (One-way ANOVA followed by Dunnette’s multiple 
comparison test), PHF (Polyherbal formulation), AST (Aspartate aminotransferase), ALT (Alanine aminotransferase), ALP (Alkaline phosphatase)  
 
Table 5: Effect of PHF on relative organ weights of male and female rats in sub-acute toxicity 
Organ Sex Organ weight (g/100 g body weight) 
Control  PHF-100 mg/kg  PHF-200 mg/kg  PHF-400 mg/kg  
Liver Female 3.11±0.12 3.16±1.13 3.10±0.16 3.02±0.12 
Male 3.26±0.02 3.27±0.02 3.24±0.03 3.25±0.03 
Kidney Female 0.45±0.01 0.47±0.02 0.44±0.02 0.45±0.02 
Male 0.51±0.03 0.53±0.03 0.49±0.03 0.50±0.3 
Spleen Female 0.24±0.02 0.23±0.01 0.22±0.01 0.25±0.02 
Male 0.27±0.04 0.29±0.05 0.30±0.05 0.29±0.03 
Heart Female 0.40±0.01 0.42±0.01 0.42±0.02 0.41±0.02 
Male 0.47±0.02 0.49±0.02 0.48±0.02 0.51±0.01 
Lung Female 0.46±0.02 0.47±0.03 0.47±0.02 0.48±0.02 
Male 0.52±0.02 0.50±0.01 0.54±0.02 0.53±0.02 
Ovary Female 0.056±0.002 0.052±0.002 0.051±0.003 0.052±0.003 
Testis Male 0.93±0.04 0.92±0.05 0.90±0.05 0.88±0.03 
Values are expressed as mean±SEM (n=10) in each group. P>0.05, when compared to control groups. (One-way ANOVA followed by Dunnette’s 
multiple comparison test), PHF (Polyherbal formulation), 
 
 
Fig. 1: Light microscopy of kidney sections from rats, sections 
was stained by hematoxylin and eosin (H&E) A: Control, B: PHF-




Fig. 2: Light microscopy of liver sections from rats, sections was 
stained by hematoxylin and eosin (H&E) A: Control, B: PHF-100 
mg/kg, C: PHF-200 mg/kg, D: PHF-400 mg/kg, PHF=Polyherbal 
formulation 
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Histopathological examination of kidney and liver 
In the sub-acute oral toxicity study, histopathological examinations 
of kidney and liver sections of rats were normal. Kidney biopsy of 
treated rats showed normal tissue cortex containing several 
glomeruli, normal capsular space, interstitial and tubules (fig. 1). 
The liver biopsy of treated rats showed a normal architecture, 
parenchymal cells, portal system, and blood sinusoids of liver 
sections. Treatment with PHF at the three dose levels (100 mg/kg, 
200 mg/kg, and 400 mg/kg) did not show any histopathological 
changes (fig. 2). 
DISCUSSION 
Plant origin drugs are known to play a vital role in the management 
various chronic diseases and have received a great preference by the 
researcher as an alternative source for allopathic pharmaceutical 
drugs in recent times [3]. Botanical medicines have become popular 
as alternative remedies as they are believed to be efficacious and 
have over a thousand years’ experience in treating patients [20]. 
Emblica officinalis, Gymnema sylvestre, Terminalia arjuna, Tinospora 
cordifolia and Zingiber officinale are well-known herbs available 
throughout India and widely used in the traditional system of 
medicine for the treatment of diabetes and various diseases. The 
safeties of these individual herbs are well known, but the combined 
effects of these herbs are uncertain. Thus, it becomes essential to 
assess the safety and toxicity of the combination of herbs (PHF) 
before their use in human. In the present studies, a series of 
preclinical experiments were performed to assess the safety and 
toxicity of PHF, such as acute and sub-acute oral toxicity studies. 
In an acute oral toxicity study, it was observed that the lethal oral 
toxicity of the PHF was estimated to be higher than 2000 mg/kg, 
classified as category 5 according to OECD Guide 423, indicating a 
certain safety margin associated with the use of PHF as therapeutic 
agents [18]. The female rats exposed, presented no toxicity and 
behavioral changes during the treatment period, as well as no 
changes in water and food intake, in relation to the control group. 
In the sub-acute oral toxicity study, the PHF treated groups did not 
show any significant changes in body weight, indicating that it did 
not have any adverse effects on body weight. Organ weight is an 
important index of the physiological and pathological status of 
animals [17].  
After 28 d of treatment, there were no treatment-related changes in 
hematological parameters between control and treated groups, 
indicating that the PHF was neither toxic to RBC, WBC and platelet 
nor interfered with their production. The hematopoietic system is 
one of the most sensitive targets of toxic compounds and is an 
important index of physiological and pathological states in man and 
animals [2, 22].  
Clinical biochemistry is mainly performed to evaluate the effect of 
PHF on hepatic and renal functions as well as on glucose and total 
cholesterol and triglyceride levels. Liver function tests are a group of 
blood tests that detect inflammation and damage to the liver. They 
also check how well the liver is working. The AST, ALT and ALP are 
the enzymes, which play an important role in liver function and have 
been used as biomarkers for predicting possible toxicity [21]. There 
was no significant increase in serum AST, ALT, ALP and total 
bilirubin and no significant decrease in total serum protein, albumin 
of treated rats when compared to the control rats. The blood glucose 
level was decreased in PHF treated rats; however, blood glucose 
level was statistically insignificant, when compared with control 
rats. This might reflect the hypoglycemic effect of PHF that may be 
due to stimulating pancreatic insulin release and reducing intestinal 
glucose absorption. There was also no significant increase in serum 
total cholesterol and triglyceride in treated rats when compared to 
the control rats. The normal levels of liver function test parameters 
indicate that the PHF did not damage and interfere with liver 
function.  
The kidneys excrete metabolic waste products and regulate the 
serum concentration of a variety of substances. The urea and 
creatinine are important biomarkers of renal toxicity [17, 20]. At 
some stage during the course of renal injury and inflammation, these 
substances often become abnormal, and the extent of the 
abnormality generally depends on the severity of the disease. The 
normal levels of serum urea and creatinine, total protein and albumin 
indicate that the PHF did not interfere with renal function, and renal 
integrity was preserved. There was no significant increase in serum urea 
and creatinine and no significant decreased in serum total protein and 
albumin of treated rats when compared to the control rats. 
The organ (liver, kidney, spleen, heart, lung, ovary, and testis) 
weights in the PHF treated rats remained normal, indicating that 
PHF was not toxic in these vital organs [23]. The liver and kidney 
play an important role in metabolism and excretion of drugs, hence, 
it was necessary to examine the liver and kidney tissues 
histopathologically, in order to detect any microscopic changes that 
might be present [2]. Examination of liver and kidney sections taken 
from rats treated sub-acutely with PHF did not show any 
histopathological changes, which comply with the normal pattern of 
biochemical parameters when they compared with control rats. 
These findings could explain the previously mentioned normal liver 
enzyme (ALT, AST and ALP) levels. Similarly, histopathological 
examination of kidney sections from rats treated sub-acutely with 
PHF did not show histopathological changes.  
CONCLUSION 
The acute oral toxicity study indicated that PHF can be classified as 
category 5 or is a low-toxic substance according to globally 
harmonized system. The sub-acute administration of PHF at the 
three dose levels did not show any toxic effect on hematological, 
biochemical and histopathological parameters in rats. The data 
obtained in this study are relevant as they provide for the use of PHF 
of great economic and medical importance. However, further studies 
in animals and humans should be performed (such as chronic 
toxicity and developmental, reproductive and carcinogenic study) in 
order to evaluate the total safety of polyherbal formulation. 
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